News

The following statement regarding report that Idaho, Kansas, and Missouri have been granted access to challenge the FDA’s abortion drugs policies can be attributed to Dr. Christina Francis, board-certified OB-GYN and CEO of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG): “For years the FDA has failed to provide basic protections for women and […]

CC: The Board of Directors of the American College of Obstetricians and Gynecologists  Dear Dr. Brooks,  We are the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), an organization of over 7,000 obstetrician-gynecologists and other medical professionals committed to defending the lives and dignity of our pregnant and preborn patients.  Over the past two years,

To be attributed to Dr. Susan Bane, MD, PhD, Board-Certified OB-GYN and Board Vice Chair at the American Association of Pro-Life Obstetricians and Gynecologists According to reports, Candi Miller died because she believed misinformation about abortion drugs and laws — false narratives that are enthusiastically promoted by mainstream media and abortion advocates, and that scared

Statement regarding ProPublica’s recent piece; attribute to Dr. Christina Francis, CEO of AAPLOG Amber Thurman’s tragic death, recently covered by multiple news organizations, was caused by side effects of legal abortion drugs and medical negligence, not pro-life laws. Despite taking the drugs as she was instructed and seeking timely care when she experienced complications, she still died. Rather than highlighting

As the second anniversary of the U.S. Supreme Court Decision in Dobbs v. Jackson Women’s Health Center approaches, we must fight false narratives about women’s healthcare.  We are more committed than ever to ensuring that both our maternal and fetal patients receive exceptional healthcare that respects the dignity of each person. We are also committed

Whatever your position on abortion, we should all be able to agree that women deserve excellent, evidence-based healthcare. Despite the fact that today’s ruling allows the FDA’s reckless actions to continue for now, nothing changes the fact that the FDA’s own label for these abortion drugs says that roughly one in 25 women who take